Search for tag: "monoamine"

5 Media

54:07 CP2 CNS4 Anxiolytics and Antidepressants Dr Phil… CP2 CNS4 Anxiolytics and Antidepressants Dr Phil Larkman	CP2 CNS4 Anxiolytics and Antidepressants Dr Phil Larkman Drugs use to treat anxiety and affective disorders drugs anxiety symptoms benzodiazepines depression disorders brain disorder monoamine action antidepressants effects hippocampus behaviour amygdala mechanisms mechanism stress symptomology oxidase From Philip Larkman 0 likes 79 plays 0 Licence Type Creative Commons - Attribution
12:18 Pharmacology 3: Parkinson's Disease - Part 3… Pharmacology 3: Parkinson's Disease - Part 3 Dr Phil Larkman	Pharmacology 3: Parkinson's Disease - Part 3 Dr Phil Larkman Drug treatment dopa dopamine treatment brain disease parkinson levels patient effect drug decarboxylase drugs oxidase conversion ganglia basal methyltransferase monoamine symptoms receptors From Philip Larkman 0 likes 155 plays 0 Licence Type Creative Commons - Attribution
04:41 Pharmacology 3: Antidepressant Drugs - Part 4 Dr… Pharmacology 3: Antidepressant Drugs - Part 4 Dr Phil Larkman	Pharmacology 3: Antidepressant Drugs - Part 4 Dr Phil Larkman Future perspectives drugs antidepressant depression hypothesis theory monoamine release receptors effects receptor glutamate mechanisms neurotransmission disorders activation disinhibition action mechanism ketamine hippocampus From Philip Larkman 0 likes 141 plays 0 Licence Type Creative Commons - Attribution
15:30 Pharmacology 3: Antidepressant Drugs - Part 2 Dr… Pharmacology 3: Antidepressant Drugs - Part 2 Dr Phil Larkman	Pharmacology 3: Antidepressant Drugs - Part 2 Dr Phil Larkman Theory of Depression drugs monoamine depression symptoms levels antidepressants cortisol noradrenalin theory release evidence actions serotonin patients pathway hippocampus neurons neurotransmitters brain disorders From Philip Larkman 0 likes 175 plays 0 Licence Type Creative Commons - Attribution
13:12 Pharmacology 3: Antidepressant Drugs - Part 3 Dr… Pharmacology 3: Antidepressant Drugs - Part 3 Dr Phil Larkman	Pharmacology 3: Antidepressant Drugs - Part 3 Dr Phil Larkman Mechanisms of action, pharmacokinetics and unwanted effects. drugs antidepressants effects inhibitors monoamine noradrenalin oxidase generation interactions depression antidepressant serotonin range patients activity uptake reuptake actions target profile From Philip Larkman 0 likes 194 plays 0 Licence Type Creative Commons - Attribution

the university of edinburgh

The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336, VAT Registration Number GB 592 9507 00, and is acknowledged by the UK authorities as a “Recognised body” which has been granted degree awarding powers.

Any views expressed within media held on this service are those of the contributors, should not be taken as approved or endorsed by the University, and do not necessarily reflect the views of the University in respect of any particular issue.

Search for tag: "monoamine"

CP2 CNS4 Anxiolytics and Antidepressants Dr Phil Larkman

Pharmacology 3: Parkinson's Disease - Part 3 Dr Phil Larkman

Pharmacology 3: Antidepressant Drugs - Part 4 Dr Phil Larkman

Pharmacology 3: Antidepressant Drugs - Part 2 Dr Phil Larkman

Pharmacology 3: Antidepressant Drugs - Part 3 Dr Phil Larkman

the university of edinburgh